About Seagull BioSolutions
Seagull BioSolutions is a Healthcare company based in Pune (India) founded in 2011 by Shruti Vishwas Joshi. Developer of new technologies for healthcare applications. Seagull BioSolutions has raised $126.67 thousand across 5 funding rounds from investors including ICICI Bank, Department of Scientific and Industrial Research and Startups at Venture Center. Seagull BioSolutions was last valued at $84.85 thousand in March 2012. Its Indian entity Seagull Biosolutions Private Limited reported revenue of ₹53.5 Lakh. Seagull BioSolutions offers products and services including eSAME Technology and Active Virosome Technology. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics.
Company details
Founded in 2011 in Pune, India, Seagull BioSolutions operates in the biotechnology sector. A mammalian expression system known as eSAME technology is utilized by the company for producing recombinant proteins, viral vaccines, therapeutic agents, and gene therapy components. An oncolytic virus candidate, SBPL-0100, is being advanced to target prostate and other cancer cells selectively. Virosomes for dengue vaccines are also under development.
- Headquarters Pune, India
- Founders Shruti Vishwas Joshi
- SectorsHealthcare
- Website seagullbiosolutions.in
- Social LinkedIn Facebook
- Legal Name Seagull Biosolutions Private Limited
- Date of Incorporation 06 May, 2011
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹53.5 Lakh
FY 2025 · -69% YoY
- Net Loss-₹41.5 Lakh
FY 2025 · -78% margin
- EBITDA-₹25.8 Lakh
FY 2025 · -48% margin
- Total Equity Funding$126.67K (USD)
in 5 rounds
- InvestorsICICI Bank
& 7 more
Associated legal entities of Seagull BioSolutions
Seagull BioSolutions operates through Seagull Biosolutions Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Seagull Biosolutions Private Limited CIN U74900PN2011PTC139460 | Active | 06 May 2011 | Pune, Maharashtra | ₹0.5 Cr | 3 | View details |
Products & Services of Seagull BioSolutions
Seagull BioSolutions offers a comprehensive portfolio of products and services, including eSAME Technology and Active Virosome Technology.
Develops healthcare products using innovative biological methods.
Advances virosome-based solutions for affordable medical applications.
Funding Insights of Seagull BioSolutions
Seagull BioSolutions has successfully raised a total of $126.67K across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $126,665
- Total Rounds 5
- Investors Count 8
All 5 funding rounds of Seagull BioSolutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2013 | Grant | – | – | ||
| Jul 2012 | $45,360 | Seed | – | Venture Center | – |
| May 2012 | $44,555 | Seed | – | Startups at Venture Center | – |
| Mar 2012 | $36,750 | Angel Round | $84,848 | Shailendra Maheshwari | |
| Mar 2012 | Seed | – | Department of Scientific and Industrial Research | – |
Last known valuation $84,848 (Mar 2012). 8 investors in total: 4 institutional and 4 angel.
Investors in Seagull BioSolutions
Seagull BioSolutions has secured backing from 8 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include ICICI Bank, Department of Scientific and Industrial Research and Startups at Venture Center.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startups are incubated at Venture Center, backed by CSIR. | venturecenter.co.in | Pune, India | ||
Startup incubator focused on science business | startups.venturecenter.co.in | |||
Commercial bank | 1994 | icicibank.com | Mumbai, India | |
Scientific and industrial research promotion and technology development services in India. | 1985 | dsir.gov.in | Delhi, India | |
SM Shailendra Maheshwari | unknown_89d18dcb28964e59a | |||
VM Vinita Maheshwari | unknown_ef77149175fa458a8 | |||
VD Vishwas Dattatraya Joshi | Angel investor and tech entrepreneur with focus on early-stage startups in India. | unknown_2443ca5abdf24abcb | ||
SJ Shruti Joshi | unknown_60285c2adf2b4d9ab |
Investor details for Seagull BioSolutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Seagull Biosolutions Private Limited (Seagull BioSolutions)
Seagull Biosolutions Private Limited is the primary company behind Seagull BioSolutions. The board of Seagull Biosolutions Private Limited currently have 3 directors; the longest-serving is Vishwas Dattatraya Joshi, appointed in 2011. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vishwas Dattatraya Joshi DIN 03506096 | Managing Director | 06 May 2011 | 15 yrs 6 mo | Seagull Biosolutions Private Limited |
| Shruti Vishwas Joshi DIN 03506121 | Director | 06 May 2011 | 15 yrs 6 mo | Seagull Biosolutions Private Limited |
| Shailendra Maheshwari DIN 03604004 | Director | 07 Oct 2011 | 15 yrs | Seagull Biosolutions Private Limited |
People of Seagull BioSolutions
1 people are tracked at Seagull BioSolutions (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership |
Complete people profiles for Seagull BioSolutions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Seagull BioSolutions
Figures of Seagull Biosolutions Private Limited, the primary company behind Seagull BioSolutions, for FY 2025. Revenue was ₹53.5 Lakh (-69% year on year). Net loss was -₹41.5 Lakh (-78% margin). EBITDA was -₹25.8 Lakh (-48% margin). Revenue has grown at a compounded annual rate of -3% over three years and +1% over five years.
- ₹53.5 LakhRevenue · FY 2025 · -69% YoY
- -₹41.5 LakhNet loss · -78% margin
- -₹25.8 LakhEBITDA · -48% margin
- ₹15.3 LakhPaid-up capital
- -3%Revenue CAGR, 3 years
- +1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Seagull Biosolutions Private Limited are on its company page.
Detailed financial statements for Seagull BioSolutions
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Seagull BioSolutions
3 dated milestones of Seagull BioSolutions across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Seagull BioSolutions is founded.
- Funding First funding round.
- Funding Latest funding round, Grant,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Seagull Biosolutions
Complete news archive for Seagull BioSolutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Seagull BioSolutions
Seagull BioSolutions was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Seagull BioSolutions is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Seagull BioSolutions is a funded company, having raised a total of $126.67K across 5 funding rounds to date.
The primary company behind Seagull BioSolutions, Seagull Biosolutions Private Limited, reported revenue of ₹53.5 Lakh for FY 2025, down 69% year on year.
Founded in 2011 in Pune, India, Seagull BioSolutions operates in the biotechnology sector. A mammalian expression system known as eSAME technology is utilized by the company for producing recombinant proteins, viral vaccines, therapeutic agents, and gene therapy components. An oncolytic virus candidate, SBPL-0100, is being advanced to target prostate and other cancer cells selectively. Virosomes for dengue vaccines are also under development.
Seagull BioSolutions offers eSAME Technology and Active Virosome Technology.
Seagull BioSolutions has 8 investors. Key investors include ICICI Bank, Department of Scientific and Industrial Research, Startups at Venture Center, Venture Center, and Shailendra Maheshwari.
The valuation of Seagull BioSolutions is $84.85K as of Mar 2012.
Seagull BioSolutions operates through Seagull Biosolutions Private Limited.
The legal entities of Seagull BioSolutions currently have 3 directors, including Shailendra Maheshwari, Vishwas Dattatraya Joshi, Shruti Vishwas Joshi.